Mirikizumab

ATC L04AC24 · 8 markets · 31 records

Mirikizumab 8 markets · 31 records Forms

CA 7 records · 4 strengths

AU 7 records · 2 strengths

  • 100 mg/mLinjectionOMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection autoinjector (pre-filled pen) composite pack (citrate-free formulation)OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation)、OMVOH mirikizumab 100 mg/mL solution for injection autoinjector (pre-filled pen)、OMVOH mirikizumab 100 mg/mL solution for injection autoinjector (pre-filled pen) (citrate-free formulation)、OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe、OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe (citrate-free formulation) unknown
  • 20 mg/mLinjectionOMVOH mirikizumab 300 mg/15 mL (20 mg/mL) concentrated injection vial for IV infusion unknown

US 5 records · 2 strengths

GB 4 records · 3 strengths

ES 3 records · 3 strengths

TW 2 records · 2 strengths

MX 1 records · 1 strengths

    Records without a stated strength · 1 Omvoh

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Omvoh

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.